Are Patients with COVID-19 Dying of or with Cardiac Injury?
作者信息
Tsolaki Vasiliki, Zakynthinos George E
机构信息
University of Thessaly Faculty of MedicineLarissa, Greece.
出版信息
Am J Respir Crit Care Med. 2020 Jul 15;202(2):300-301. doi: 10.1164/rccm.202004-1083LE.
Abstract
摘要
相似文献
1
Are Patients with COVID-19 Dying of or with Cardiac Injury?新型冠状病毒肺炎患者是死于心脏损伤还是伴有心脏损伤？
Am J Respir Crit Care Med. 2020 Jul 15;202(2):300-301. doi: 10.1164/rccm.202004-1083LE.
2
Reply to Tsolaki and Zakynthinos: Are Patients with COVID-19 Dying of or with Cardiac Injury?回复索拉基和扎金索斯：2019冠状病毒病患者是死于心脏损伤还是伴有心脏损伤？
Am J Respir Crit Care Med. 2020 Jul 15;202(2):301-303. doi: 10.1164/rccm.202004-1156LE.
3
Cardiac injury and prognosis in COVID-19: Methodological considerations and updated meta-analysis.COVID-19 中的心脏损伤与预后：方法学考量及更新的荟萃分析
J Infect. 2020 Aug;81(2):e181-e182. doi: 10.1016/j.jinf.2020.06.031. Epub 2020 Jun 18.
4
Cardiac injury and mortality in COVID-19: A reappraisal.新型冠状病毒肺炎中的心脏损伤与死亡率：重新评估
J Infect. 2020 Sep;81(3):e35-e36. doi: 10.1016/j.jinf.2020.06.068. Epub 2020 Jun 30.
5
COVID-19 and myocardial injury.新型冠状病毒肺炎与心肌损伤
CMAJ. 2020 Jul 13;192(28):E812-E813. doi: 10.1503/cmaj.201230. Epub 2020 Jun 24.
6
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.2019冠状病毒病（COVID-19）与心肌损伤及死亡率的关联
JAMA Cardiol. 2020 Jul 1;5(7):751-753. doi: 10.1001/jamacardio.2020.1105.
7
Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study.新冠病毒感染患者的亚临床急性肾损伤：一项回顾性队列研究。
Nephron. 2020;144(7):347-350. doi: 10.1159/000508502. Epub 2020 May 26.
8
Does active smoking worsen Covid-19?主动吸烟会使新冠肺炎恶化吗？
Eur J Intern Med. 2020 Jul;77:129-131. doi: 10.1016/j.ejim.2020.05.038. Epub 2020 May 28.
9
Is spinal anaesthesia an aerosol-generating procedure? Transmission of SARS-CoV-2 from patient to anaesthetist.脊髓麻醉是一种产生气溶胶的操作吗？严重急性呼吸综合征冠状病毒2从患者传播给麻醉医生。
Br J Anaesth. 2020 Sep;125(3):e315. doi: 10.1016/j.bja.2020.06.015. Epub 2020 Jun 15.
10
Surveillance for COVID-19 in Cardiac Inpatients: Containing COVID-19 in a Specialized Cardiac Centre.心脏科住院患者的COVID-19监测：在专业心脏中心防控COVID-19
Can J Cardiol. 2020 Aug;36(8):1327.e3-1327.e4. doi: 10.1016/j.cjca.2020.05.031. Epub 2020 May 29.
引用本文的文献
1
SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure.SCARLET（补充胞磷胆碱治疗降低肺损伤疗效试验）：一项单中心、双盲、安慰剂对照、随机 1/2 期临床试验的研究方案，旨在评估静脉注射胞磷胆碱（胞二磷胆碱）治疗 SARS-CoV-2 感染合并低氧性急性呼吸衰竭住院患者的疗效。
Trials. 2024 May 18;25(1):328. doi: 10.1186/s13063-024-08155-0.
2
New-Onset Atrial Fibrillation in the Critically Ill COVID-19 Patients Hospitalized in the Intensive Care Unit.入住重症监护病房的危重症COVID-19患者新发房颤
J Clin Med. 2023 Nov 8;12(22):6989. doi: 10.3390/jcm12226989.
3
Secondary bacterial infections are a leading factor triggering New Onset Atrial Fibrillation in intubated ICU Covid-19 ARDS patients.继发性细菌感染是导致插管 ICU 中 COVID-19 合并急性呼吸窘迫综合征患者新发心房颤动的主要因素。
J Infect Public Health. 2022 Jul;15(7):766-772. doi: 10.1016/j.jiph.2022.06.006. Epub 2022 Jun 16.
4
Brief review: Cardiac complications and platelet activation in COVID-19 infection.简要综述：新型冠状病毒肺炎感染中的心脏并发症与血小板活化
Afr J Thorac Crit Care Med. 2020 Sep 16;26(3). doi: 10.7196/AJTCCM.2020.v26i3.107. eCollection 2020.
5
Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.致编辑的信：大邱广域市新冠肺炎住院患者心血管危险因素及心血管疾病对预后的影响
J Korean Med Sci. 2021 Apr 19;36(15):e113. doi: 10.3346/jkms.2021.36.e113.
6
The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review.免疫系统、肾素-血管紧张素-醛固酮系统（RAAS）与 RAAS 抑制剂之间的相互作用可能会调节 COVID-19 的转归：系统评价。
J Clin Pharmacol. 2021 Aug;61(8):987-1000. doi: 10.1002/jcph.1852. Epub 2021 Apr 7.
本文引用的文献
1
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study.85 例武汉 COVID-19 死亡病例的临床特征。一项回顾性观察研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379. doi: 10.1164/rccm.202003-0543OC.
2
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).新冠肺炎（COVID-19）患者的心脏受累。
JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.
3
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.新冠肺炎住院患者中心脏损伤与死亡的相关性研究：中国武汉。
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Pathophysiology of Takotsubo Syndrome.Takotsubo 综合征的病理生理学。
Circulation. 2017 Jun 13;135(24):2426-2441. doi: 10.1161/CIRCULATIONAHA.116.027121.
6
New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients.关于脓毒症患者B型利钠肽升高的机制及其预后价值的新见解。
Crit Care. 2014 May 9;18(3):R94. doi: 10.1186/cc13864.
Zotero 插件